News & Updates
Filter by Specialty:
Intensive rehab benefits lung cancer patients undergoing surgery
A rehabilitation programme comprising intensive perioperative pulmonary rehabilitation (PR) and standard of care (SC) led to improved exercise capacity and tolerance in individuals with early-stage non-small-cell lung cancer (NSCLC) who are undergoing lung resection, the PUREAIR trial suggests.
Intensive rehab benefits lung cancer patients undergoing surgery
11 Jan 2022
Pyrotinib + capecitabine extends OS in metastatic breast cancer
Patients with previously treated HER2-positive metastatic breast cancer (mBC) experienced a 31 percent reduced risk of death when treated with pyrotinib plus capecitabine than lapatinib plus capecitabine, according to updated results of the phase III PHOEBE trial from China.
Pyrotinib + capecitabine extends OS in metastatic breast cancer
10 Jan 2022
5α-reductase inhibitors help reduce SARS-CoV-2 infection risk in men
Use of 5α-reductase inhibitors (5ARIs) appears to lower the risk of community-acquired infection with SARS-CoV-2 in men without prostate cancer, according to a study, noting that treatment with this drug class can help ease the burden of COVID-19.
5α-reductase inhibitors help reduce SARS-CoV-2 infection risk in men
10 Jan 2022
Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns
The coronavirus disease 2019 (COVID-19) pandemic has led to a sharp decline in treatment for older patients with newly diagnosed cancers of the digestive system, a recent study has found.
Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns
10 Jan 2022
Disease-modifying agents for multiple sclerosis do not elevate cancer risk
Several disease-modifying therapies (DMTs) for multiple sclerosis (MS) do not pose an increased risk of cancer, a study has shown.